APA aipamena

Cardin, D. B., Thota, R., Goff, L. W., Berlin, J. D., Jones, C., Ayers, G. D., . . . Chan, E. (2018). A Phase II study of Ganetespib as second- or third-line therapy for metastatic pancreatic cancer. Am J Clin Oncol.

Chicago Style aipamena

Cardin, Dana B., Ramya Thota, Laura W. Goff, Jordan D. Berlin, C.M Jones, Gregory D. Ayers, Jennifer G. Whisenant, and Emily Chan. "A Phase II Study of Ganetespib As Second- or Third-line Therapy for Metastatic Pancreatic Cancer." Am J Clin Oncol 2018.

MLA aipamena

Cardin, Dana B., et al. "A Phase II Study of Ganetespib As Second- or Third-line Therapy for Metastatic Pancreatic Cancer." Am J Clin Oncol 2018.